Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial Comparing the Effects of Orally Administered Xyrem(R) (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia.
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2012
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Fibromyalgia; Sleep disorders
- Focus Therapeutic Use
- Sponsors Jazz Pharmaceuticals Inc; Orphan Medical
- 03 Aug 2010 Secondary outcome measures (sleep) published in The Journal of rheumatology.
- 11 Jun 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History